About 7,030,000 results
Open links in new tab
  1. Non-Small Cell Lung Cancer (NSCLC): Symptoms & Treatment

    Jan 16, 2025 · Non-small cell lung cancer is the most common type of lung cancer. It grows slowly. But it can spread to other parts of your body before you notice symptoms.

  2. Non-small-cell lung cancer - Wikipedia

    Non-small-cell lung cancer accounts for about 85% of all lung cancers. [1][2][3] As a class, non-small-cell lung cancers are relatively insensitive to chemotherapy, compared to small-cell …

  3. Non-Small Cell Lung Cancer Treatment - NCI

    May 16, 2025 · Non-small cell lung cancer is a type of cancer that forms in the tissues of the lung. There are several types of non-small cell lung cancer. Smoking is the major risk factor for non …

  4. Update 2025: Management of Non‑Small-Cell Lung Cancer - PMC

    Lung cancer remains the leading cause of cancer-related mortality worldwide. Since 2024, the non–small-cell lung cancer (NSCLC) landscape has undergone a transformative shift, driven …

  5. Non-Small-Cell Lung Cancer: Causes, Symptoms, and Treatment

    May 14, 2025 · What Is Non-Small-Cell Lung Cancer (NSCLC)? Most people who have lung cancer have NSCLC. Although it's serious, treatment can sometimes stop it from getting …

  6. Non-small-cell lung cancer - Nature Reviews Disease Primers

    Sep 26, 2024 · Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is responsible for the majority of cancer-related deaths worldwide. The management of …

  7. Non-Small Cell Lung Cancer (NSCLC) | Boehringer Ingelheim

    Learn more about Non-Small Cell Lung Cancer (NSCLC), the most common type of lung cancer, making up about 85% of all lung cancer cases.

  8. Non-small cell lung cancer: MedlinePlus Medical Encyclopedia

    Jun 3, 2024 · Non-small cell lung cancer is the most common type of lung cancer. It usually grows and spreads more slowly than small cell lung cancer.

  9. Non-small Cell Lung Cancer Treatment by Stage

    Learn about treatment options for non-small cell lung cancer (NSCLC), including surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.

  10. FDA Grants Breakthrough Status to Sevabertinib in 1L HER2+ NSCLC

    Jan 6, 2026 · Sevabertinib targets HER2 and EGFR mutations, showing efficacy in HER2 exon 20 insertions and point mutations in NSCLC. The SOHO-01 study reported a 59% overall …